Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand

Journal of Clinical Investigation

Volumn 100, Issue 10, 1997, Pages 2622-2633

  Georgescu, Liviu ^b   Vakkalanka, Radha Krishna ^b   Elkon, Keith B ^b   Crow, Mary K ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b NONE

Author keywords

Activation induced cell death; Apoptosis; Fas ligand; Interleukin 10; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; FAS ANTIGEN; INTERLEUKIN 10; LIGAND;

ADULT; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC VASCULITIS; T LYMPHOCYTE;

EID: 0030778080     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119806     Document Type: Article

References (68)

1. Hardin, J.A. 1986. The lupus autoantigens and the pathogenesis of systemic lupus erythematosus. Arthritis Rheum. 29:457-160.
2. Mohan, C., S. Adams, V. Stanik, and S.K. Datta. 1993. Nucleosome. A major immunogen for pathogenic autoantibody-inducing T cells of lupus. J. Exp. Med. 177:1367-1381.
3. Crow, M.K., G. DelGiudice-Asch, J.B. Zehetbauer, J.L. Lawson, N. Brot, H. Weissbach, and K.B. Elkon. 1994. Autoantigen-specific T cell proliferation induced by the ribosomal P2 protein in patients with systemic lupus eryhematosus. J. Clin. Invest. 94:345-352.
4. Mysler, E., P. Bini, J. Drappa, P. Ramos, S.M. Friedman, P.M. Krammer, and K.B. Elkon. 1994. The apoptosis-1/Fas protein in human systemic lupus erythematosus. J. Clin. Invest. 93:1029-1034.
5. Ohsako, S., M. Hara, M. Harigai, C. Fukasawa, and S. Kashiwazaki. 1994. Expression and function of Fas antigen and bcl-2 in human systemic lupus erythematosus lymphocytes. Clin. Immunol. Immunopathol. 73:109-114.
6. Tsokos, G.C. 1992. Lymphocyte abnormalities in human lupus. Clin. Immunol. Immunopathol. 63:7-9.
7. Dayal, A.K., and G.M. Kammer. 1996. The T cell enigma in lupus. Arthritis Rheum. 39:23-33.
8. Llorente, L., Y. Richaud-Patin, J. Wijdenes, J. Alcocer-Varela, M.C. Maillot, I. Durand-Gasselin, B.M. Fourrier, P. Galanaud, and D. Emilie. 1993. Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus. Eur. Cytokine Netw. 4:421-427.
9. Llorente, L., Y. Richaud-Patin, R. Fior, J. Alcocer-Varela, J. Wijdenes, B.M. Fourrier, P. Galanaud, and D. Emilie. 1994. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjogren's syndrome, and systemic lupus erythematosus. Arthritis Rheum. 37:1647-1655.
10. Houssiau, F.A., C. Lefebvre, M. Vanden Berghe, M. Lambert, J.-P. Devogelaer, and J.-C. Renauld. 1995. Serum interleukin 10 in systemic lupus erythematosus reflect disease activity. Lupus. 4:393-395.
11. Llorente, L., W. Zou, Y. Levy, Y. Richaud-Patin, J. Wijdenes, J. Alcocer-Varela, B. Morel-Fourrier, J.C. Brouet, D. Alarcon-Segovia, and P. Galanau. 1995. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J. Exp. Med. 181:839-844.
12. Hagiwara, E., M.F. Gourley, S. Lee, and D.M. Klinman. 1996. Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10: interferon-g-secreting cells in the peripheral blood. Arthritis Rheum. 39:374-385.
13. Linker-Israeli, M., R.J. Deans, D.J. Wallace, J. Prehn, T. Ozeri-Chen, and J.R. Klinenberg. 1991. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. J. Immunol. 147:117-123.
14. Koshy, M., D. Berger, and M.K. Crow. 1996. Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J. Clin. Invest. 98: 826-837.
15. Desai-Mehta, A., L. Lu, R. Ramsey-Goldman, and S.K. Datta. 1996. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J. Clin. Invest. 97:2063-2073.
16. Gottlieb, A.B., R.G. Lahita, N. Chiorazzi, and H.G. Kunkel. 1479. Immune function in systemic lupus erythematosus. Impairment of in vitro T-cell proliferation and in vivo antibody response to exogenous antigen. J. Clin. Invest. 63:885-892.
17. Iliopoulos, A.G., and G.C. Tsokos. 1996. Immunopathogenesis and spectrum of infections in SLE. Semin. Arthritis Rheum. 25:318-336.
18. Emlen, W., J. Niebur, and R. Kadera. 1994. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J. Immunol. 152:3685-3692.
19. Akbar, A.N., N.J. Borthwick, R.G. Wickremasinghe, P. Panayiotidis, D. Pilling, M. Bofill, S. Krajewski, J.C. Reed, and M. Salmon. 1996. Interleukin-2 receptor common g-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xs) gene expression. Eur. J. Immunol. 26:294-299.
20. Wesselborg, S., O. Janssen, and D. Kabelitz. 1993. Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells. J. Immunol. 150:4338-4345.
21. Salmon, M., D. Pilling, N.J. Borthwick, N. Viner, G. Janossy, P.A. Bacon, and A.N. Akbar. 1994. The progressive differentiation of primed T cells is associated with an increasing susceptibility to apoptosis. Eur. J. Immunol. 24: 892-899.
22. Dhein, J., H. Walczak, C. Baumler, K.-M. Debatin, and P.H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature. 373: 438-441.
23. Zheng, L., G. Fisher, R.E. Miller, J. Peschon, R.E. Lynch, and M.J. Lenardo. 1995. Induction of apoptosis in mature T cells by tumor necrosis factor. Nature. 377:348-351.
24. Bombardier, C., D.D. Gladman, M.D. Urowitz, D. Caron, C.H. Chang, and the Committee on Prognosis Studies in SLE. 1992. Derivation of the SLE-DAI: a disease activity index (SLEDAI) for lupus patients. Arthritis Rheum. 35: 630-640.
25. Tanaka, M., T. Suda, K. Haze, N. Nakamura, K. Sato, F. Kimura, K. Motoyoshi, M. Mizuki, S. Tagawa, S. Ohga, et al. 1996. Fas ligand in human serum. Nat. Med. 2:317-322.
26. Nicoletti, I., G. Migliorati, M.C. Paglliacci, F. Grignani, and C. Riccardi. 1992. A rapid and simple method for measuring thymocyte apoptosis induced by DNA damaging agents. J. Exp. Med. 176:1043-1051.
27. Ashany, D., X. Song, E. Lacy, J. Nikolic-Zugic, S.M. Friedman, and K.B. Elkon. 1995. Th1 CD4+ lymphocytes delete activated macrophages through the Fas/APO-1 antigen pathway. Proc. Natl. Acad. Sci. USA. 92:11225-11229.
28. Ding, L., and E.M. Shevach. 1992. IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. J. Immunol. 148:3133-3139.
29. Malefyt, R.D.W., H. Yssel, and J. de Vries. 1993. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J. Immunol. 150:4754-4765.
30. Taga, K., H. Mostowski, and G. Tosato. 1993. Human interleukin-10 can directly inhibit T cell growth. Blood. 81:2964-2971.
31. Romano, M.F., A. Lamberti, A. Petrella, R. Bisogni, P. Tassone, S. Formisano, S. Venuta, and M.C. Turco. 1996. IL-10 inhibits nuclear factor-B/ Rel nuclear activity in CD3-stimulated human peripheral blood T lymphocytes. J. Immunol. 156:2119-2123.
32. Ozawa, H., S. Aiba, S. Nakagawa, and H. Tagami. 1996. Interferon-gamma and interleukin-10 inhibit antigen presentation by Langerhans cells for T helper type 1 cells by suppressing their CD80 (B7-1) expression. Eur. J. Immunol. 26:648-652.
33. Taga, K., and G. Tosato. 1991. IL-10 inhibits human T cell proliferation and IL-2 production. J. Immunol. 148:1143-1148.
34. D'Andrea, A., M. Aste-Amezaga, N. Valiente, X. Ma, M. Kubin, and G. Trinchieri. 1993. Interleukin-10 (IL-10) inhibits human lymphocyte interferon-g production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178:1041-1048.
35. Estaquier, J. 1995. T helper type 1/T helper type 2 cytokines and T cell death: preventive effect of Interleukin 12 on activation-induced and CD95 (FAS/APO-1)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons. J. Exp. Med. 182:1759-1767.
36. Murphy, E.E., G. Terres, S.E. Macatonia, C.S. Hsieh, J. Mattson, L. Lanier, M. Wysocka, G. Trinchieri, K. Murphy, and A. O'Garra. 1994. B7 and interleukin 12 cooperate for proliferation and interferon gamma production by mouse T helper clones that are unresponsive to B7 costimulation. J. Exp. Med. 180:223-231.
37. Brunetti, M., N. Martelli, A. Colasante, M. Piantelli, P. Musiana, and F.B. Aiello. 1995. Spontaneous and glucocorticoid-induced apoptosis in human mature T lymphocytes. Blood. 86:4199-4205.
38. Cui, H.D., H. Sherr, M. El-Khatib, K. Matsui, D.J. Panka, A. Marshak-Rothstein, and S.T. Tu. 1996. Regulation of T-cell death genes: selective inhibition of FasL- but not Fas-mediated function. Cell. Immunol. 167:276-284.
39. Adachi, Y., N. Oyaizu, S. Than, T.W. McCloskey, and S. Pahwa. 1996. IL-2 rescues in vitro lymphocyte apoptosis in patients with HIV infection. Correlation with its ability to block culture-induced down-modulation of Bcl-2. J. Immunol. 157:4184-4193.
40. Estaquier, J., M. Tanaka, T. Suda, S. Nagata, P. Golstein, and J.C. Ameisen. 1446. Fas-mediated apoptosis of CD4+ and CD8+ T cells from human immunodeficiency virus-infected persons: differential in vitro preventive effect of cytokines and protease antagonists. Blood. 87:4959-4946.
41. Groux, H., G. Torpier, D. Monte, Y. Mouton, A. Capron, and J.C. Ameisen. 1442. Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J. Exp. Med. 175:331-340.
42. Teodorczyk-Injeyan, J.A., M. Cembrzynska-Nowak, S. Lalani, W.J. Peters, and G.B. Mills. 1995. Immune deficiency following thermal trauma is associated with apoptotic cell death. J. Clin. Immunol. 15:318-328.
43. Zajac, A.J., D.G. Quinn, P.L. Cohen, and J.A. Frelinger. 1996. Fas-dependent CD4+ cytotoxic T-cell-mediated pathogenesis during virus infection. Proc. Natl. Acad. Sci. USA. 93:14730-14735.
44. Nakamura, K., K. Yuh, S. Sugyo, H. Shijo, N. Kimura, and M. Okumura. 1996. Apoptosis observed in peripheral T lymphocytes from patients with chronic hepatitis B. Gastroenterology. 111:156-164.
45. Mignon-Godefroy, K., O. Rott, M.P. Brazillet, and J. Charreire. 1945. Curative and protective effects of IL-10 in experimental autoimmune thyroiditis (EAT). Evidence for IL-10-enhanced cell death in EAT. J. Immunol. 154: 6634-6643.
46. Fluckiger, A.C., I. Durand, and J. Banchereau. 1944. Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells. J. Exp. Med. 179:91-44.
47. Ludewig, B., D. Graf, H.R. Gelderblom, Y. Becker, R.A. Kroczek, and G. Pauli. 1995. Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNF-alpha, but strongly enhanced by interleukin-10. Eur. J. Immunol. 25:1943-1950.
48. Groux, H., M. Bigler, J.E. De Vries, and M.-G. Roncarlo. 1996. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J. Exp. Med. 184:19-29.
49. Kawamura, T., and M. Furue. 1995. Comparative analysis of B7-1 and B7-2 expression in Langerhans cells: differential regulation by T helper type 1 and T helper type 2 cytokines. Eur. J. Immunol. 25:1913-1917.
50. Kaneko, H., K. Saito, H. Hashimoto, H. Yagita, K. Okumura, and M. Azuma. 1996. Preferential elimination of CD28+ T cells in systemic lupus erythematosus (SLE) and the relation with activation-induced apoptosis. Clin. Exp. Immunol. 106:218-229.
51. Clerici, M., T.A. Wynn, J.A. Berzofsky, S.P. Blatt, C.W. Hendrix, A. Sher, R.L. Coffman, and G.M. Shearer. 1994. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J. Clin. Invest. 93:768-775.
52. Akridge, R.E., L.K. Oyafuso, and S.G. Reed. 1994. IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages. J. Immunol. 153:5782-5789.
53. Ransohoff, R.M., and M.M. Dustoor. 1983. Impaired autologous mixed lymphocyte reaction with normal concanavalin A-induced suppression in adult polymyositis/dermatomyositis. Clin. Exp. Immunol. 53:67-75.
54. Cambridge, G., A. Faith, C. Saunders, and V. Dubowitz. 1989. A comparative study of in vitro proliferative responses to mitogens and immunoglobulin production in patients with inflammatory muscle disease. Clin. Exp. Rheumatol. 7:27-33.
55. Russell, P.J., T.J. Doolan, J. Webb, and G.A. Carr. 1983. Studies of autologous mixed lymphocyte reactions in patients with systemic lupus erythematosus. Pathology. 15:37-43.
56. Evans, J.A., K.J. Pasi, and F.G. Hill. 1995. Evidence for the aetiological role of blood-borne virus infections in causing reduced lectin-induced T-cell proliferation in haemophilic boys. Br. J. Haematol. 91:197-212.
57. Chisari, F.V., K.L. Castle, C. Xavier, and D.S. Anderson. 1981. Functional properties of lymphocyte subpopulations in hepatitis B virus infection. I. Suppressor cell control of T lymphocyte responsiveness. J. Immunol. 126:38-44.
58. Lafrado, L.J., M.A. Javadian, J.M. Marr, K.A. Wright, J.C. Kelliher, C.S. Dezzutti, L. Cummins, and R.G. Olsen. 1991. Lymphocyte and neutrophil dysfunction associated with hepatitis B virus and hepatitis non-A, non-B virus infection in the chimpanzee. J. Med. Primatol. 20:302-307.
59. Horgan, A.F., M.V. Mendez, D.S. O'Riordain, R.G. Holzheimer, J.A. Mannick, and M.L. Rodrick. 1994. Altered gene transcription after burn injury results in depressed T-lymphocyte activation. Ann. Surg. 220:342-351.
60. Eisner, M.D., J. Amory, B. Mullaney, L. Tierney, Jr., and W.S. Browner. 1996. Necrotizing lymphadenitis associated with systemic lupus erythematosus. Sem. Arthritis Rheum. 26:477-482.
61. Bell, D.A., and B. Morrison. 1991. The spontaneous apoptotic cell death of normal human lymphocytes in vitro: the release of, and immunoproliferative response to nucleosomes in vitro. Clin. Immumol. Immunopathol. 60:13-26.
62. Bell, D.A., B. Morrison, and F. VandenBygaart. 1990. Immunogenic DNA-related factors. Nucleosomes spontaneously released from normal murine lymphoid cells stimulate proliferation and immunoglobulin synthesis of normal mouse lymphocytes. J. Clin. Invest. 85:1487-1496.
63. Casciola-Rosen, L.A., G. Anhalt, and A. Rosen. 1994. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179:1317-1330.
64. Casciola-Rosen, L.A., G.J. Anhalt, and A. Rosen. 1995. DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J. Exp. Med. 182:1625-1634.
65. Ishida, H., T. Muchamuel, S. Sakaguchi, S. Andrade, S. Menon, and M. Howard. 1994. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J. Exp. Med. 179:305-310.
66. Itoh, K., and S. Hirohata. 1995. The role of IL-10 in human B cell activation, proliferation, and differentiation. J. Immunol. 154:4341-4350.
67. Malisan, F., F. Briere, J.M. Bridon, N. Harindranath, F.C. Mills, H.E. Max, J. Banchereau, and H. Martinez-Valdez. 1996. Interleukin-10 induces immunoglobulin G isotype switch recombination in human CD40-activated naive B lymphocytes. J. Exp. Med. 183:937-947.
68. Finbloom, D.S., and K.D. Wineslock. 1995. IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1a and STAT3 complexes in human T cells and monocytes. J. Immunol. 155:1079-1090.